St. Louis encephalitis other diagnostic studies: Difference between revisions
(Created page with "__NOTOC__ {{St. Louis encephalitis}} {{CMG}} {{AE}}: {{VVS}} ==Overview== ==References== {{reflist|2}} {{WH}} {{WS}} Category:Needs content Category:Disease [[Category...") |
|||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}}: {{VVS}} | {{CMG}} {{AE}}: {{VVS}} | ||
==Overview== | ==Overview== | ||
==Other Diagnostic Studies== | |||
SLEV is difficult to isolate from clinical samples and almost all isolates have come from brain tissue or CSF. In the absence of a sensitive and non-invasive virus detection method, serologic testing is the primary method for diagnosing SLEV infection. Combined with a consistent clinico-epidemiologic presentation, a rapid and accurate diagnosis of acute neuroinvasive SLEV disease can be made by the detection of SLEV-specific IgM antibody in serum or CSF. SLEV IgM tests are available commercially, in some state health department laboratories, and at CDC. A positive SLEV IgM test result should be confirmed by neutralizing antibody testing of acute- and convalescent-phase serum specimens at a state public health laboratory or CDC. To submit specimens for testing at CDC, contact your state health department. All SLEV disease cases should be reported to local public health authorities. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 15:37, 21 November 2012
|
St. Louis encephalitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
St. Louis encephalitis other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of St. Louis encephalitis other diagnostic studies |
|
Risk calculators and risk factors for St. Louis encephalitis other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: : Vishnu Vardhan Serla M.B.B.S. [2]
Overview
Other Diagnostic Studies
SLEV is difficult to isolate from clinical samples and almost all isolates have come from brain tissue or CSF. In the absence of a sensitive and non-invasive virus detection method, serologic testing is the primary method for diagnosing SLEV infection. Combined with a consistent clinico-epidemiologic presentation, a rapid and accurate diagnosis of acute neuroinvasive SLEV disease can be made by the detection of SLEV-specific IgM antibody in serum or CSF. SLEV IgM tests are available commercially, in some state health department laboratories, and at CDC. A positive SLEV IgM test result should be confirmed by neutralizing antibody testing of acute- and convalescent-phase serum specimens at a state public health laboratory or CDC. To submit specimens for testing at CDC, contact your state health department. All SLEV disease cases should be reported to local public health authorities.